Quote | Lipocine Inc. (NASDAQ:LPCN)
|Last Trade Date Time:||06/09/2023 03:00:00 am|
News | Lipocine Inc. (NASDAQ:LPCN)
Lipocine to Present LPCN 1148 and LPCN 1144 at the EASL Congress 2023 PR Newswire Phase 2 proof-of-concept study of LPCN 1148 in male cirrhotic patients with sarcopenia is fully enrolled with topline 24-week results expected mid-2023 SALT LAKE CITY , June 7, 2023...
2023-05-16 09:47:57 ET Lipocine ( NASDAQ: LPCN ) stock fell ~6% on Tuesday after reporting data from a pilot pharmacokinetic (PK) bridge study of LPCN 1154 (oral brexanolone), versus IV brexanolone for postpartum depression (PPD). The study enrolled 12 people and e...
Message Board Posts | Lipocine Inc. (NASDAQ:LPCN)
|$LPCN short squeeze signal||RunninRobert||investorshub||05/12/2023 7:26:37 AM|
|Bottom was in on the eighth||Triple nickle||investorshub||05/11/2023 4:27:09 PM|
|Added||Triple nickle||investorshub||05/11/2023 4:25:38 PM|
|Time for this to show some returns||gi197845||investorshub||05/11/2023 4:04:56 AM|
|$LPCN Found an interesting article||gi197845||investorshub||05/10/2023 6:49:32 PM|
Lipocine Inc. Company Name:
LPCN Stock Symbol:
Lipocine Inc. Website:
News, Short Squeeze, Breakout and More Instantly...